CMA-CGM has launched a new pharmaceutical shipping service with enhanced end-to-end guarantees. The firm has a track record of using new services to build market share. The move comes as U.S. imports of pharmaceuticals reached $74.4 billion in the 12 months to Mar. 31. CMA-CGM already attained a 17.4% share of U.S. seaborne imports of pharmaceuticals in the 12 months to Apr. 30. That still left it well behind sector leaders Maersk and MSC with 22.4% and 19.4% respectively. The largest import route is from India, which accounted for 26.0% of seaborne imports and was led by Aurobindo and C...